Evidence map›Paper›PMID 38035025›Full record

ArticleFrontiers in pharmacology2023

Human N-acetyltransferase 2 (

Márcia Quinhones P Lopes, Raquel Lima F Teixeira, Pedro Hernan Cabello, José Augusto C Nery, Anna Maria Sales, Edilbert Pellegrini Nahn J R, Marilda Vieira Moreira, Ewalda Von Rosen Stahlke, Lia Gonçalves Possuelo, Maria Lucia R Rossetti and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.Clinical pharmacology and therapeutics · 2026
    Review
  4. Pharmacogenomic heterogeneity ofAnnals of medicine · 2025
    Observational
  5. Review
  6. Article
  7. Determination ofPharmaceutics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Márcia Quinhones P LopesLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Raquel Lima F TeixeiraLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Pedro Hernan CabelloLaboratory of Human Genetics, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
José Augusto C NeryLeprosy Laboratory, Souza Araújo Outpatient Clinic, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Anna Maria SalesLeprosy Laboratory, Souza Araújo Outpatient Clinic, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Edilbert Pellegrini Nahn J RLeprosy Outpatient Clinic, Northern Fluminense State University, Campos dos Goytacazes, RJ, Brazil.
Marilda Vieira MoreiraHoly House of Mercy of Espírito Santo, Vitória, ES, Brazil.
Ewalda Von Rosen StahlkeMetropolitan Regional Specialty Center, Curitiba, PR, Brazil.
Lia Gonçalves PossueloDepartment of Molecular Biology and Biotechnology, IB and Biotechnology Center, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Maria Lucia R RossettiDepartment of Molecular Biology and Biotechnology, IB and Biotechnology Center, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Marcelo F RabahiAnuar Auad Infectious Disease Reference Hospital, Goiania, GO, Brazil.
Luciana F M SilvaMunicipal Secretary of Health of Palmas, Palmas, TO, Brazil.
Patrícia Almeida LemeMunicipal Secretary of Health of Gurupi, Gurupi, TO, Brazil.
William John WoodsCoordination of Sanitary Dermatology, Rio Branco, AC, Brazil.
Mauricio Lisboa NobreGiselda Trigueiro Hospital, Natal, RN, Brazil.
Maria Leide Wan-Del-Rey de OliveiraSector of Dermatology, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Kazuê NarahashiPolyclinic Oswaldo Cruz, Porto Velho, RO, Brazil.
Milde CavalcantiPolyclinic Clementino Fraga, Recife, PE, Brazil.
Philip Noel SuffysLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Sotiria BoukouvalaLaboratory of Molecular Genetics and Pharmacogenomics - Toxicogenomics, Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Maria Eugênia N GalloLeprosy Laboratory, Souza Araújo Outpatient Clinic, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Adalberto Rezende SantosLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

admixed populationhuman NAT2N-acetyltransferase 2polymorphismssequencing

Identifiers

PMID38035025
PMCPMC10684696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.